Innate immune response to Rift Valley fever virus in goats

• Published in: PLoS neglected tropical diseases 2012-04, Vol.6 (4), p.e1623-e1623
• Main Authors: Nfon, Charles K, Marszal, Peter, Zhang, Shunzhen, Weingartl, Hana M
• Format: Article
• Language: English
• Subjects: Abortion; Animals; Antibodies; Antibodies, Neutralizing - blood; Antibodies, Viral - blood; Aquatic insects; Biology; Care and treatment; Cell Line; Cytokines; Cytokines - secretion; Development and progression; Diseases; Fever; Goat Diseases - immunology; Goat Diseases - virology; Goats; Immune response; Immunity, Innate; Infections; Insect bites; Leukocytes, Mononuclear - virology; Mammals; Medicine; Mortality; Mosquitoes; Pathogenesis; Proteins; Rift Valley fever; Rift Valley Fever - immunology; Rift Valley Fever - veterinary; Rift Valley fever virus - immunology; RNA polymerase; Sheep; Subpopulations; Time Factors; Tropical diseases; Vaccines; Vector-borne diseases; Veterinary Science; Viruses
• ISSN: 1935-2735; 1935-2727; 1935-2735
• DOI: 10.1371/journal.pntd.0001623

Rift Valley fever (RVF), a re-emerging mosquito-borne disease of ruminants and man, was endemic in Africa but spread to Saudi Arabia and Yemen, meaning it could spread even further. Little is known about innate and cell-mediated immunity to RVF virus (RVFV) in ruminants, which is knowledge required for adequate vaccine trials. We therefore studied these aspects in experimentally infected goats. We also compared RVFV grown in an insect cell-line and that grown in a mammalian cell-line for differences in the course of infection. Goats developed viremia one day post infection (DPI), which lasted three to four days and some goats had transient fever coinciding with peak viremia. Up to 4% of peripheral blood mononuclear cells (PBMCs) were positive for RVFV. Monocytes and dendritic cells in PBMCs declined possibly from being directly infected with virus as suggested by in vitro exposure. Infected goats produced serum IFN-γ, IL-12 and other proinflammatory cytokines but not IFN-α. Despite the lack of IFN-α, innate immunity via the IL-12 to IFN-γ circuit possibly contributed to early protection against RVFV since neutralising antibodies were detected after viremia had cleared. The course of infection with insect cell-derived RVFV (IN-RVFV) appeared to be different from mammalian cell-derived RVFV (MAM-RVFV), with the former attaining peak viremia faster, inducing fever and profoundly affecting specific immune cell subpopulations. This indicated possible differences in infections of ruminants acquired from mosquito bites relative to those due to contact with infectious material from other animals. These differences need to be considered when testing RVF vaccines in laboratory settings.